epigallocatechin gallate has been researched along with isobavachalcone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, YS | 1 |
| Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X | 1 |
| Chen, R; Chung, SK; Hamdoun, S; Ip, CK; Jiang, H; Li, R; Liu, L; Qu, Y; Wong, VKW; Yang, L; Yang, Z; Zhang, D | 1 |
2 review(s) available for epigallocatechin gallate and isobavachalcone
| Article | Year |
|---|---|
Recent advances in natural antifungal flavonoids and their derivatives.
Topics: Antifungal Agents; Biological Products; Flavonoids; Fungi; Humans; Mycoses | 2019 |
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries | 2020 |
1 other study(ies) available for epigallocatechin gallate and isobavachalcone
| Article | Year |
|---|---|
Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry.
Topics: Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; Binding, Competitive; Biological Products; Catechin; Cell Membrane; Chalcones; Chlorogenic Acid; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Ginsenosides; Humans; Interferometry; Mice, Inbred C57BL; Molecular Dynamics Simulation; Phenols; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |